Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MANNKIND CORPMNKD · Entity 4792 | Chief Medical Officer | July 31, 2020 | August 04, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MANNKIND CORP
Report date July 31, 2020 · Filed August 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 Par ValueSEC Table I · non-derivative | Direct | 41,059 |
Reported balance
After 2020-07-31 transaction · row 1
1 source rowRow 1 · 2020-07-31 · Purchase · Acquired 4,041 · Balance 41,059 F1: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2020 Filed Aug 4, 2020 22:39 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 4,041 | $1.25 | $5,051.25 |
DisclosureSEC source: 0001209191-20-044829 · doc4.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,059 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2020. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 22:54 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 15,136 | $1.51 | $22,855.36 |
DisclosureSEC source: 0001209191-20-011689 · doc4.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,018 F1 · shares: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 02:15 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 2,304 | $0.95 | $2,188.80 |
DisclosureSEC source: 0001209191-20-006173 · doc4.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,154 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2020. Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 00:44 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 5,000 | $0.95 | $4,750.00 |
DisclosureSEC source: 0001209191-19-043926 · doc4.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,850 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on July 31, 2019 representing the maximum allowable under the Plan for this period. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:22 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 234,000 | $1.32 Strike: $1.32 | $308,880.00 |
DisclosureSEC source: 0001209191-19-030371 · doc4.xml · derivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,000 Underlying: Stock Options · 234,000 shares Expires 2029-05-14 F1 · kind: Annual Equity Award: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
| February 20, 2019 Filed Feb 25, 2019 11:05 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantRestricted Stock Unit | 37,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012814 · doc4.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,850 F1 · shares: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock. F2 · shares: Restricted stock units shall vest and be delivered on February 20, 2020. Read SEC document |
| January 31, 2019 Filed Jan 31, 2019 23:12 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 5,000 | $1.07 | $5,350.00 |
DisclosureSEC source: 0001209191-19-006271 · doc4.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,824 F1 · kind: The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2019 representing the maximum allowable under the Plan for this period. Read SEC document |
| November 14, 2018 Filed Nov 15, 2018 23:11 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantCommon Stock, $0.01 Par Value | 2,824 | $1.77 | $4,998.48 |
DisclosureSEC source: 0001209191-18-058796 · doc4.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,824 Read SEC document |
| November 14, 2018 Filed Mar 13, 2019 16:20 UTC Amendment | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $0.01 Par Value | 2,824 | $1.77 | $4,998.48 |
DisclosureSEC source: 0001209191-19-019066 · doc4a.xml · nonDerivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,824 Read SEC document |
| May 16, 2018 Filed May 18, 2018 14:14 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 53,500 | $1.91 Strike: $1.91 | $102,185.00 |
DisclosureSEC source: 0001209191-18-031286 · doc4.xml · derivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,500 Underlying: Stock Options · 53,500 shares Expires 2028-05-16 F1 · kind: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
| February 21, 2018 Filed Feb 27, 2018 23:37 UTC | MANNKIND CORP MNKD · Entity 4792 | GrantEmployee Stock Option (right to buy) · Derivative | 180,100 | $2.76 Strike: $2.76 | $497,076.00 |
DisclosureSEC source: 0001209191-18-014209 · doc4.xml · derivative · entry 1 Kendall David M · CIK 0001732647 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,100 Underlying: Stock Options · 180,100 shares Expires 2029-02-12 F1 · kind: 25% vesting on the anniversary of the vesting determination date and 1/48th per month thereafter; being fully vested on the fourth anniversary of the vesting determination date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.